Internal Medicine · Rosemead, CA
NPI
1679635353
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
3925 Rosemead Blvd, Suite 101
Rosemead, CA, 91770
Phone (626) 573-9090
Groups this clinician bills Medicare through
Medicare paid, 2024
$877K
13,085 services
Medicare patients, 2024
847
Average age 75
Drug cost, 2024
$4.0M
38,401 prescriptions
Company payments, 2025
$3,566
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David Y Lin was code 99232 (hospital e&m - subsequent), 3,181 times for 233 patients. In total David Y Lin billed 13,085 services in 21 codes, and Medicare paid $877K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 3,181 | 233 | $65.49 | $208K |
| 99214 Office E&M - Established | Office | 2,090 | 548 | $99.72 | $208K |
| 99213 Office E&M - Established | Office | 1,877 | 415 | $77.64 | $146K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,620 | 483 | $13.82 | $22K |
| 99308 SNF E&M | Office | 1,259 | 157 | $63.02 | $79K |
| 99497 Care Management/Coordination | Office | 404 | 404 | $86.73 | $35K |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 404 | 404 | $27.10 | $11K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 404 | 404 | $21.31 | $8,609 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 373 | 373 | $141.71 | $53K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 363 | 363 | $21.31 | $7,734 |
| 99223 Hospital E&M - Initial | Facility | 266 | 178 | $142.91 | $38K |
| 90656 Vaccine Product | Office | 235 | 235 | $21.90 | $5,147 |
| G0008 Administration of influenza virus vaccine | Office | 234 | 234 | $24.50 | $5,733 |
| 99306 SNF E&M | Office | 177 | 156 | $152.48 | $27K |
| 99309 SNF E&M | Office | 78 | 53 | $91.13 | $7,108 |
By year: 2022 $885K for 11,824 services; 2023 $920K for 12,126 services; 2024 $877K for 13,085 services.
Medicare prescription drug claims, 2024
In 2024, the drug David Y Lin prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,211 prescriptions and refills. In total David Y Lin wrote 38,401 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,211 | 3,487 | 404 | $19K |
| Amlodipine Besylate Generic | 1,794 | 2,918 | 351 | $9,214 |
| Losartan Potassium Generic | 1,164 | 2,040 | 242 | $8,938 |
| Levothyroxine Sodium Generic | 978 | 1,528 | 166 | $10K |
| Omeprazole Generic | 856 | 1,292 | 206 | $6,097 |
| Tamsulosin Hcl Generic | 838 | 1,378 | 171 | $9,702 |
| Metformin Hcl Generic | 740 | 1,179 | 150 | $6,135 |
| Famotidine Generic | 673 | 805 | 104 | $6,651 |
| Rosuvastatin Calcium Generic | 637 | 1,169 | 139 | $7,356 |
| Donepezil Hcl Generic | 629 | 875 | 102 | $6,217 |
| Pantoprazole Sodium Generic | 608 | 708 | 98 | $17K |
| Metoprolol Succinate Generic | 598 | 952 | 118 | $6,851 |
| Clopidogrel Clopidogrel Bisulfate | 556 | 841 | 101 | $4,720 |
| Gabapentin Generic | 553 | 740 | 111 | $7,422 |
| Celecoxib Generic | 528 | 821 | 131 | $14K |
Brand drugs: 5,436 claims; generic drugs: 32,553 claims; opioid claims: 260.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David Y Lin $3,566 ($3,566 in general payments such as food, travel and fees) from 28 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $448.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 12 | $448 |
| Teva Pharmaceuticals USA, Inc. TEVA | 6 | $442 |
| Pfizer Inc. PFE | 10 | $319 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $223 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $165 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $163 |
| Lundbeck LLC | 7 | $159 |
| GlaxoSmithKline, LLC. GSK | 3 | $156 |
| Madrigal Pharmaceuticals MDGL | 1 | $150 |
| Vivus LLC | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.